GetTopicDetailResponse(id=7c6e10858461, topicName=瑞派替尼, introduction=瑞派替尼, content=伊馬替尼 胃腸道間質(zhì)瘤 瑞派替尼, image=null, comments=0, allHits=1339, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Thu Dec 14 10:07:07 CST 2023, time=2023-12-14, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=459294, tagList=[TagDto(tagId=459294, tagName=瑞派替尼)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2188992, encodeId=40932188992c9, content=<a href='/topic/show?id=330410333110' target=_blank style='color:#2F92EE;'>#黑色素瘤#</a> <a href='/topic/show?id=7c6e10858461' target=_blank style='color:#2F92EE;'>#瑞派替尼#</a>, objectTitle=大咖談 | “靶”握未來(lái)：瑞派替尼治療KIT突變黑色素瘤新選擇, objectType=article, longId=814283, objectId=31c281428393, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-doctor-hand-with-pen-BWV9L2K.jpg, objectUrl=/article/show_article.do?id=31c281428393, replyNumber=0, likeNumber=96, createdTime=2024-02-23, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=31c281428393, moduleTitle=大咖談 | “靶”握未來(lái)：瑞派替尼治療KIT突變黑色素瘤新選擇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=31c281428393)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2186216, encodeId=37922186216fb, content=<a href='/topic/show?id=3cc88658264' target=_blank style='color:#2F92EE;'>#舒尼替尼#</a> <a href='/topic/show?id=5dd28335eea' target=_blank style='color:#2F92EE;'>#胃腸道間質(zhì)瘤#</a> <a href='/topic/show?id=02982402298' target=_blank style='color:#2F92EE;'>#二線治療#</a> <a href='/topic/show?id=594853956a' target=_blank style='color:#2F92EE;'>#ctDNA#</a> <a href='/topic/show?id=7c6e10858461' target=_blank style='color:#2F92EE;'>#瑞派替尼#</a>, objectTitle=Nat Med：胃腸道間質(zhì)瘤二線治療選瑞派替尼or舒尼替尼？血液ctDNA揭曉答案, objectType=article, longId=812546, objectId=c1938125467e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016299208_4754896.png, objectUrl=/article/show_article.do?id=c1938125467e, replyNumber=0, likeNumber=137, createdTime=2024-02-06, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=c1938125467e, moduleTitle=Nat Med：胃腸道間質(zhì)瘤二線治療選瑞派替尼or舒尼替尼？血液ctDNA揭曉答案, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c1938125467e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174877, encodeId=707f21e4877c5, content=<a href='/topic/show?id=c52225680c6' target=_blank style='color:#2F92EE;'>#伊馬替尼#</a> <a href='/topic/show?id=5dd28335eea' target=_blank style='color:#2F92EE;'>#胃腸道間質(zhì)瘤#</a> <a href='/topic/show?id=7c6e10858461' target=_blank style='color:#2F92EE;'>#瑞派替尼#</a>, objectTitle=瑞派替尼二線治療胃腸道間質(zhì)瘤的療效和安全性俱佳，尤其KIT Ex11突變，詳解2023ASCO公布INTRIGUE中國(guó)橋接試驗(yàn), objectType=article, longId=804834, objectId=a8b28048349a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=a8b28048349a, replyNumber=0, likeNumber=151, createdTime=2023-12-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a8b28048349a, moduleTitle=瑞派替尼二線治療胃腸道間質(zhì)瘤的療效和安全性俱佳，尤其KIT Ex11突變，詳解2023ASCO公布INTRIGUE中國(guó)橋接試驗(yàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a8b28048349a)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2023-12-14發(fā)表于上海
